Skip to content

Core Stabalization and Rebound Therapy and CP

Effect of Core Stabalization Versus Rebound Therapy on Balance in Children With Cerebral Palsy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05739396
Enrollment
26
Registered
2023-02-22
Start date
2023-02-01
Completion date
2023-07-11
Last updated
2023-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Balance, cp, Rebound Therapy, Whole Body Vibration

Brief summary

the study aims to compare the effect of core stabalization and rebound therapy on balance in children with hemiplegic cerebral palsy

Detailed description

PURPOSE: To compare the effect of core stabilization and rebound therapy on balance in children with hemiplegic cerebral palsy BACKGROUND: Cerebral palsy is primarily a disorder of movement and posture HYPOTHESES: There is no significant difference between core stabilization and rebound therapy on balance in children with hemiplegic cerebral palsy. RESEARCH QUESTION: Is there a significant difference between core stabilization and rebound therapy on balance in children with hemiplegic cerebral palsy?

Interventions

OTHERcore stabilization

The treatment session lasted one hour with short breaks of around 10 minutes and will be conducted three times per week for twelve successive weeks

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
5 Years to 8 Years
Healthy volunteers
No

Inclusion criteria

* children diagnosed with spastic hemiplegic CP. * Their chronological age ranged from 5 to 8 years, * able to follow verbal commands or instructions during testing procedures, * degree of spasticity in affected lower limbs ranged between1 to 1+ according to Modified Ashworth scale (MAS), * they are able to understand and follow instructions given to them,

Exclusion criteria

* Children who had significant visual or auditory problems that may interfere with testing, - ---- patients who had contractures or fixed deformities related to the joints of the lower limbs, ---- injection with Botulinium toxin or any orthopaedic surgery in lower limbs 6m before study, * children who were suffering from cardiopulmonary problems or epilepsy.

Design outcomes

Primary

MeasureTime frameDescription
balance12 weekit measures the degree of tilting for each axis during dynamic conditions and calculates a medial lateral stability index (MLSI); an anterior-posteriorstability index (APSI); and an overall stability index(OSI),

Secondary

MeasureTime frameDescription
gross motor function measure-8812 weekmeasure gross motor function. higher scores indicate better outcome. scores are reported in percentage.
lafayette hand held dynamometer12 weekmeasure isometric muscle strength of knee flexors and extensors. higher scores reflect better outcome
6 minute walk test12 weekmeasure endurance.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026